Buy Glytsifonovaya ointment 30% ointment 10 g
  • Buy Glytsifonovaya ointment 30% ointment 10 g

Methyl Phosphonic Acid

Tatkhimpharmpreparaty
1977 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$259.31
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Glyciphonic ointment shows a local effect in tumors and pretumor diseases of the skin. Selectively inhibits metabolism in blastomatous cells, which is explained by antimitotic effect, especially pronounced in the acidic environment of the tumor tissue. It also has antimicrobial activity.

Indications

  • squamous cell skin cancer stage I;
  • basal cell carcinoma (including tumor recurrence after surgical treatment and radiation therapy);
  • Bowen disease;
  • senile keratosis.

Composition

10 g contains glyciphon 3 g
excipients: vaseline medical; anhydrous lanolin
in banks or aluminum tubes of 10 g.

No customer reviews for the moment.

Write your review

Write your review

Methyl Phosphonic Acid

Dosage and Administration

Locally. Apply 0.8–2.0 g of ointment (depending on the size of the focus) on the skin in the tumor growth zone or keratosis, previously rubbed with an alcohol swab, covered with gauze cloth and fixed with adhesive tape. At each ligation, the focus and the surrounding skin are rubbed with alcohol, the necrotic tissue is removed. Applications are carried out daily, 1 time per day until complete destruction of the tumor tissue. The duration of treatment is determined by the location and size of the lesion.
In the treatment of recurrent tumors, small-basal forms of basaliomas in the forehead and nose make 15-20 applications, with ulcers, with surface type basal cell carcinomas and Bowen's disease - 10-15, with senile keratosis - 5-10 applications.
After completing the course, dressings are applied daily (aseptic or with antiseptic ointments) to the resulting defect until complete scarring.

Adverse reactions

Erythema of the periorbital region, hyperemia, edema (in these cases, treatment takes a break for 2-3 days and prescribe lotions with a solution of nitrofural or ointment with GCS, after a break, treatment is continued); pain at the site of application (to reduce pain, you can simultaneously apply 5–10% ointment with benzocaine on the focus).

Contraindications

Hypersensitivity to the drug components, pregnancy, breastfeeding period, children's age.
Carefully:
Carefully apply the drug on the skin areas located near the periorbital area. Avoid contact with eyes.

Drug interactions

Drug interaction of the drug Glyciphonic ointment 30% is not described.

Pregnancy and Lactation

Contraindicated in pregnancy. At the time of treatment should stop breastfeeding.

  • Brand name: Glyciphonic ointment 30%
  • Active ingredient: Methyl Phosphonic Acid
  • Manufacturer: Tatkhimpharmpreparaty
  • Country of Origin: Russia

Studies and clinical trials of Methyl Phosphonic Acid (Click to expand)

  1. Potentiometric Studies of Binary and Ternary Complexes Involving Cadmium(II) and Nitrilo-Tris(Methyl Phosphonic Acid) with Amino Acids, peptides and DNA Constituents
  2. N-Alkyl thiocarbamoyl phosphonic acid esters—2: Alkylation by methyl iodide accompanied by phosphonate dealkylation
  3. Novel synthesis of a mixed phosphonic anhydride. A route to carboxylic acid derivatives from a methyl ketone
  4. Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor
  5. AXAD-16-3,4-dihydroxy benzoyl methyl phosphonic acid: a selective preconcentrator for U and Th from acidic waste streams and environmental samples
  6. FT-Raman study of (hydroxypyridin-3-yl-methyl)phosphonic acid with varying pH: 2D correlation method
  7. Experimental and calculated 1H, 13C and 31P NMR spectra of (hydroxypyridin-3-yl-methyl)phosphonic acid
  8. Vibrational and structural analysis of (hydroxypyridin-3-yl-methyl)phosphonic acid
  9. Vibrational and quantum-chemical study of pH dependent molecular structures of (hydroxypyridin-4-yl-methyl)phosphonic acid
  10. Redox reaction between amino-(3,4-dihydroxyphenyl)methyl phosphonic acid and dopaquinone is responsible for the apparent inhibitory effect on tyrosinase
  11. [(4,4-Dimethyl-2-oxo-1,3-oxazolidin-3-yl)methyl]phosphonic acid
  12. Synthesis and antiviral evaluation of novel methyl branched cyclopropyl phosphonic acid nucleosides
  13. Complex Formation Equilibria Between Zinc(II), Nitrilo-tris(Methyl Phosphonic Acid) and
  14. Kinetics and Mechanism for Hydrolysis ofα-Amino Acid Esters in Mixed Ligand Complexes with Zn(II)–Nitrilo-tris(methyl phosphonic Acid)
  15. Grafting of Poly(methyl methacrylate) Brushes from Magnetite Nanoparticles Using a Phosphonic Acid Based Initiator by Ambient Temperature Atom Transfer Radical Polymerization (ATATRP)
  16. Localization of N-Methyl-d-Aspartate Receptors in the Rat Striatum: Effects of Specific Lesions on the [3H]3-(2-Carboxypiperazin-4-yl)propyl-1-Phosphonic Acid Binding
  17. Synthesis and activity of a potent N-methyl-D-aspartic acid agonist, trans-1-aminocyclobutane-1,3-dicarboxylic acid, and related phosphonic and carboxylic acids
  18. Layered Calcium Structures of p-Phosphonic Acid O-Methyl-Calix[6]arene
  19. Assignment of the Phosphorus, Proton and Carbon-NMR Spectra of [(Tetrahydro-2-hydroxy-5,5-dimethyl-4H-1,4,2-oxazaphosphorin-4-yl)methyl] phosphonic acid P-Oxide
  20. The formation of phosphorus-containing nitroxyl radicals in the photolysis of 2-methyl-2-nitrosopropane in esters of unsaturated phosphonic acid
  21. Synthesis and characterization of alcogels based on ethylene glycol methyl ether methacrylate-vinyl phosphonic acid copolymers
  22. The effects ofN-methyl-d-aspartate (NMDA) and its competitive antagonist, 3-(2-carboxypiperazine-4-yl)propyl-l-phosphonic acid (CPP), injected into caudate-putamen on kindled amygdaloid seizures in rats

8 other products in the same category:

arrow_upward